Skip to main content
. 2021 Dec 3;22(23):13085. doi: 10.3390/ijms222313085

Figure 4.

Figure 4

Mouse PET/CT imaging of SV2A with 18F-SynVesT-1. (A) Representative axial images in SV2A+ NCI-H660 tumor at five different time points and NCI-H660 tumor blocked with 19F-SynVesT-1. Tumors indicated by yellow circles. (B) Time-activity curves (TAC) of 18F-SynVesT-1 in NCI-H660 tumors and muscle. (C) TAC of 18F-SynVesT-1 in the liver, brain, bladder, and kidney. (D) Comparative uptake of 18F-SynVesT-1 and 18F-SynVesT-1 with co-injection of 19F-SynVesT-1 in tissues of interest from the imaging studies in NCI-H660. For clarity, only the data at 50–60 min is presented. * p = 0.025; ** p = 0.0082. The data are presented as mean ± SD, n = 3.